Seeing Is Believing
PBYI is currently covered by 1 analysts with an average price target of $15.1. This is a potential upside of $9.4 (164.91%) from yesterday's end of day stock price of $5.7.
Puma Biotechnology's activity chart (see below) currently has 159 price targets and 104 ratings on display. The stock rating distribution of PBYI is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 59.36% with an average time for these price targets to be met of 139.62 days.
Highest price target for PBYI is $4, Lowest price target is $4.
Most recent stock forecast was given by EDWARD WHITE from HC WAINWRIGHT on 28-Feb-2025. First documented stock forecast 02-Feb-2015.
Currently out of the existing stock ratings of PBYI, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Dec-2019
$7
$1.3 (22.81%)
$7
1 years 1 days ago
(28-Feb-2025)
10/17 (58.82%)
$3.42 (95.53%)
533
Hold Since 24-Jan-2018
$4
$-1.7 (-29.82%)
$7
2 years 3 months 26 days ago
(03-Nov-2023)
4/9 (44.44%)
$1.22 (43.88%)
92
Hold Since 05-Nov-2021
$7
$1.3 (22.81%)
$9
4 years 3 months 24 days ago
(05-Nov-2021)
4/5 (80%)
$2.99 (74.56%)
249
Sell Since 02-Nov-2018
$5
$-0.7 (-12.28%)
$6
4 years 3 months 24 days ago
(05-Nov-2021)
5/7 (71.43%)
$0.99 (24.69%)
261
Buy Since 27-Sep-2021
$11
$5.3 (92.98%)
$11
4 years 5 months 2 days ago
(27-Sep-2021)
11/24 (45.83%)
$3.88 (54.49%)
157
What is PBYI (Puma Biotechnology) average time for price targets to be met?
Which analyst has the current highest performing score on PBYI (Puma Biotechnology) with a proven track record?
Which analyst has the most public recommendations on PBYI (Puma Biotechnology)?
Which analyst is the currently most bullish on PBYI (Puma Biotechnology)?
Which analyst is the currently most reserved on PBYI (Puma Biotechnology)?